CompoAtlas

Coenzym Q10 Complex (Mit Vitaminen + Zink)

Food supplement declared in France, declaration No 2020-12-37, decision dated 1 December 2020

Coenzym Q10 Complex (Mit Vitaminen + Zink) (Vegavero) is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Malpighia glabra 120 mg per day, Vitamin E, Zinc, Ubiquinone, Son de riz. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand
Vegavero
Food business operator placing the product on the market
Vanatari International GmbH
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Capsule
Daily dose
1
Directions for use
Prenez 1 gélule par jour avec suffisamment de liquide pendant un repas.
Not recommended (according to the manufacturer)
Adolescents (under 18), Breastfeeding women, Pregnant women, Taking anticoagulants
Objectives stated by the manufacturer (these are not authorised claims)
Antioxidant, Skin, Blood and lymphatic circulation, Immunity

Declaration 171524, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Malpighia glabra L.FruitExtrait sec alcoolique120 mg

Other active ingredients

NamePer day
Ubiquinonenot declared
Son de riznot declared

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
mixed tocopherolsVitamin E300 mg30 mg
zinc citrateZinc25 mg15 mg

Additives

E464

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Photograph the packaging

Label warnings

Les compléments alimentaires ne se substituent pas à une alimentation saine et variée ni à un exercice physique régulier. Ne pas dépasser la dose journalière indiquée. L'emploi par les personnes par les femmes enceintes et allaitantes est déconseillé. Le produit ne convient pas aux enfants et aux adolescents de moins de 18 ans. Les personnes qui prennent des médicaments anticoagulants devraient consulter leur médecin avant la consommation. Tenir hors de portée des enfants. Conserver dans un endroit sombre, frais et sec.

Regulatory points

None of the rules we check applies to the declared ingredients.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Ubiquinone
    Read the warning, when it applies and the studies cited

    Coenzyme Q10 (UBIQUINONE-10)

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood pressure medication (Rosenfeldt et al. 2007; Singh et al. 1999).

    Sources cited by Health Canada (2)
    • Rosenfeldt FL, Haas SJ, Krum H, Hadj A, Ng K, Leong JY, Watts GF. Coenzyme Q10 in the treatment of hypertension: a meta-analysis of the clinical trials. Journal of Human Hypertension 2007;21(4):297-306. PubMed Meta-analysis
    • Singh RB, Niaz MA, Rastogi SS, Shukla PK, Thakur AS. Effect of hydrosoluble coenzyme Q10 on blood pressures and insulin resistance in hypertensive patients with coronary artery disease. Journal of Human Hypertension 1999;13(3):203-208. PubMed Randomised trial

    Applies to products providing more than 100 mg of Coenzyme Q10 per day.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (Engelsen et al. 2003; Landbo and Almdal 1998; Spigset 1994).

    Sources cited by Health Canada (3)
    • Engelsen J, Nielsen JD, Hansen KF. [Effect of coenzyme Q10 and Ginkgo biloba on warfarin dosage in patients on long-term warfarin treatment. A randomized, double-blind, placebo-controlled cross-over trial]. Ugeskr Laeger 2003;165(18):1868-1871 (in Danish). PubMed Randomised trial
    • Landbo C, Almdal TP. [Interaction between warfarin and coenzyme Q10]. Ugeskr Laeger 1998;160(22):3226-3227 (in Danish). PubMed Case report
    • Spigset O. Reduced effect of warfarin caused by ubidecarenone. Lancet 1994;344(8933):1372-1373. PubMed Case report

    Condition of application: Migraine prophylaxis/prevention.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if migraine frequency increases and associated nausea and vomiting persist or worsen.

    Health Canada monograph dated 31 January 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Brand : Vegavero

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Coenzym Q10 Complex (Mit Vitaminen + Zink) (Vegavero): composition and regulation”, https://compoatlas.com/en/supplements/products/171524-coenzym-q10-complex-mit-vitaminen-zink, updated 15 November 2026.

List recorded in 2020. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line